Seven Post Investment Office’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
Other funds holding CRL
IC
MG
AI
Seven Post Investment Office's CRL Position: Q4 2024 in Review
Seven Post Investment Office sold out of Charles River Laboratories (CRL) in Q4 2024, closing a stake of 1,624 shares — an estimated $320K sold.
Seven Post Investment Office first reported a position in CRL in Q3 2018 and held it in 25 quarters. The position peaked at $1.5M in Q3 2021. 637 funds tracked by Wall St. Rank hold CRL as of Q4 2024.
- Seven Post Investment Office reported no remaining Charles River Laboratories position as of Q4 2024 after selling out during the quarter.
- Seven Post Investment Office sold 1,624 Charles River Laboratories shares in Q4 2024, an estimated $320K.
- Seven Post Investment Office first reported a position in Charles River Laboratories in Q3 2018 and held it in 25 quarters.
- Seven Post Investment Office's Charles River Laboratories position peaked at $1.5M in Q3 2021.
- 637 funds tracked by Wall St. Rank held Charles River Laboratories as of Q4 2024.
Based on Seven Post Investment Office's 13F filing for Q4 2024, filed 16 Jan 2025.